Research keywords (7)：
アジュバント
, 経鼻ワクチン
, Nose to Brain drug delivery
, 経鼻投与
, 神経科学
, Drug delivery system
, 薬理学
Research theme for competitive and other funds (1)：
2013 - 2015 Identification of therapeutic targets for motor impairment resulting from Prothymosin alpha deficiency
Papers (14)：
Keita Sasaki, Shota Fukakusa, Yusuke Torikai, Chie Suzuki, Ikumi Sonohata, Takuto Kawahata, Yasuhiro Magata, Keiichi Kawai, Shunji Haruta. Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys. Journal of controlled release : official journal of the Controlled Release Society. 2023. 359. 384-399
Asuka Mizutani, Masato Kobayashi, Makoto Ohuchi, Keita Sasaki, Yuka Muranaka, Yusuke Torikai, Shota Fukakusa, Chie Suzuki, Ryuichi Nishii, Shunji Haruta, et al. Indirect SPECT Imaging Evaluation for Possible Nose-to-Brain Drug Delivery Using a Compound with Poor Blood-Brain Barrier Permeability in Mice. Pharmaceutics. 2022. 14. 5
Yusuke Torikai, Yuji Sasaki, Keita Sasaki, Akifumi Kyuno, Shunji Haruta, Akihide Tanimoto. Evaluation of Systemic and Mucosal Immune Responses Induced by a Nasal Powder Delivery System in Conjunction with an OVA Antigen in Cynomolgus Monkeys. Journal of pharmaceutical sciences. 2021. 110. 5. 2038-2046
Keita Sasaki, Sebok Kumar Halder, Hayato Matsunaga, Hiroshi Ueda. Beneficial actions of prothymosin alpha-mimetic hexapeptide on central post-stroke pain, reduced social activity, learning-deficit and depression following cerebral ischemia in mice. Peptides. 2020. 126. 170265-170265
Sebok Kumar Halder, Keita Sasaki, Hiroshi Ueda. Gγ7-specific prothymosin alpha deletion causes stress- and age-dependent motor dysfunction and anxiety. Biochemical and biophysical research communications. 2020. 522. 1. 264-269
